Management Change22 May 2026, 02:42 pm
Jubilant Pharmova Re-appoints MD and JMD
AI Summary
Jubilant Pharmova Ltd has re-appointed Mr. Priyavrat Bhartia as Managing Director and Mr. Arjun Shanker Bhartia as Joint Managing Director for a further term of three years effective from June 1, 2026, subject to shareholders' approval. Mr. Priyavrat Bhartia is the son of the company's Chairman, while Mr. Arjun Shanker Bhartia is the son of the Co-Chairman. Both are not debarred from holding their respective positions.
Key Highlights
- Priyavrat Bhartia re-appointed as Managing Director effective June 1, 2026.
- Arjun Shanker Bhartia re-appointed as Joint Managing Director effective June 1, 2026.
- Re-appointments are for a further term of 3 years, subject to shareholder approval.
- Both appointees have been associated with Jubilant Pharmova since May 2017.
- Both appointees are not debarred from holding office by any SEBI order.
Price Impact
More from JUBLPHARMA